Home  |  Terms and Conditions  |  Privacy Policy  |  Sitemap    Cookies

© Raeside Web Design

  + 44 (0) 1295 660117


Home About Us Products References Ordering Codes R & D News Contact Us

New book

Smoking – what all healthcare professionals need to know by Dr. Graham F. Cope

Available from www.mkupdate.co.uk


GFC Diagnostics

The test, called MicroScreen, detects the genes inside the antibiotic resistant bacteria and is a major breakthrough in the battle against drug resistant infection, now widely regarded as a ticking time-bomb.  Chief Medical Office, Professor Dame Sally Davies has said: “Antimicrobial resistance poses a catastrophic threat” adding that “antibiotic resistance represents a threat that may be "as important as climate change for the world".

MicroScreen presents a cheap, quick and simple test which can be used on pre-operative patients in hospital to establish if they carry antiobitic restistant bacteria, including MRSA, to to avoid uneccesssary use of antiobiotics and ensure they receive appropriate treatment for their own recovery and the well-being of other patients. .To date other tests available are complex, need to use expensive equipment and take around three days for the results to be made available

Back to top

GFC Diagnostics Wins Global Award for Development of Cheap, Quick and Simple MRSA Test

GFC Diagnostics has been awarded one of the three Longitude Prize Discovery Awards awarded to UK organisations for the company’s ground-breaking development of a test which successfully detects antibiotic resistant bacteria, including the superbug MRSA, within 30 minutes.

The GFC team, from left: chief executive Bruce Savage, technical director Dr Graham Cope, senior scientist Dr Graham Mock and scientist Alex Savage.

A FIRM based near Banbury has scooped a Longitude Prize Discovery award for developing a test for superbugs.

GFC Diagnostics’ MicroScreen detects antibiotic-resistant bacteria, such as MRSA, in 30 minutes compared to existing tests which take three days.

The new method is also cheaper, as it does not need expensive equipment or highly trained staff.

Chief executive Bruce Savage explained: “This could be a major step forward to reduce the harm caused by drug-resistant bacteria.

“This rapid test will give a quick diagnosis and prevent the unnecessary use of broad spectrum antibiotics.

“It will reduce healthcare costs by helping to stop the spread of deadly infections throughout a hospital.”

GFC Diagnostics Team

Test to seek superbugs wins top prize

30th November 2016


Bicester Advertiser